Fourth quarter and full year results 2010 - 27 January 2011

Title Dur Video
Interview in full 17:41 Play
Financial results 3:50 Play
Drug portfolio and pipeline 2:32 Play
AstraZeneca's R&D 6:28 Play
Shareholder returns 1:32 Play
Outlook and strategy 3:17 Play

  • You are watching the interview with
    David Brennan, CEO and
    Martin Mackay, President, R&D